This compound is a pharmaceutical intermediate used as an impurity reference standard for amikacin. It is structurally related to the aminoglycoside antibiotic amikacin and serves as a quality control standard in pharmaceutical manufacturing.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1793053-92-5
(2S)-4-amino-N-[(1R,4R,5R)-5-amino-4-[(2R,4R,5S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-2-[(2S,4S,5S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
pharmaceutical raw material
1,3-Di-HABA Kanamycin A
aminoglycoside antibiotic intermediate
1,6'-Di-HABA Kanamycin A
amikacin impurity reference standard
Tert-butyl N-(4-oxocyclohexyl)carbamate
pharmaceutical intermediate
(R)-BoroLeu-(+)-Pinanediol trifluoroacetate
impurity or intermediate for bortezomib synthesis
1-(4,5-Dihydrothiazol-2-yl)azetidine-3-thiol hydrochloride
Pharmaceutical intermediate for Tebipenem
(2R,4S)-tert-butyl 4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate
Pharmaceutical intermediate
Amikacin Impurity 11
Amikacin impurity reference standard
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxycyclohexyl]-2-hydroxybutanamide
HMOKJJPLZODRRD-BCUZZYETSA-N
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O)N